University of Ankara   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Ankara Turkey (1946)

Organization Overview

First Clinical Trial
2005
NCT01012843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Ankara Diskapi Yildirim Beyazit Teaching and Research Hospital, Turkey. | Ankara Education and Research Hospital | Ankara Numune Training and Research Hospital | Ankara Numune Training and Research hospital, Anesthesiology and Reanimation Clinic | Ankara Training and Resarch Hospital | Ankara Training and Research Hospital | Ankara University | Ankara University Department of Anesthesiology and Intensive Care Medicine | Ankara University Faculty of Medicine | Ankara University Faculty of Medicine Gastroenterology Department | Ankara University Medical Faculty | Ankara University Medical Faculty, Department of Cardiovascular Surgery Ankara, Turkey, 06340 | Ankara University Medical Faculty, Department of Hematology Ankara, Turkey | Ankara University Medical Faculty Dept. of Endocrinology and Metabolism | Ankara University Medical Faculty, Medical Oncology Department, Sihhiye 06100 Ankara, Turkey | Ankara University School of Medicine | Ankara Univ. Med. Fac, Chest Disease Dept | Anlara University Chief of Neonatology | Cihangir Akyol | Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine | Department of Pediatric Nephrology, School of Medicine, Ankara University, Ankara, Turkey | Diskapi Yildirim Beyazit Education and Research Hospital | Diskapi Yildirim Beyazit Teaching and research Hospital | DISKAPI YILDIRIM BEYAZIT TEACHING HOSPITAL | Dışkapı Yıldırım Beyazıt Training and Research Hospital | Dispapi yildirim beyazit E R hospital | Dr | Physical Medicine and Rehabilitation | University of Medical Sciences, Ministry of Health, Ankara City Hospital, Department of Urology, Ankara, Turkey | Yildirim Beyazit Education and Research Hospita | Yildirim Beyazit Education and Research Hospital

Active Ingredients

Drugs in Phase 4 Trials (32)

acetaminophen (tylenol) (3 trials)

acetylsalicylic acid (aspirin) (1 trial)

atorvastatin (lipitor) (1 trial)

benzydamine (1 trial)

bupivacaine (Exparel) (4 trials)

cefazolin (ancef) (1 trial)

chlorhexidine (hibitane) (1 trial)

chlorobenzene (1 trial)

codeine (Phenergan) (2 trials)

desmopressin (ddavp) (1 trial)

dexamethasone (1 trial)

dexmedetomidine (precedex) (2 trials)

epinephrine (levophed) (1 trial)

esmolol (brevibloc) (2 trials)

gentamicin (garamycin) (1 trial)

granisetron (kytril) (1 trial)

levobupivacaine (chirocaine) (9 trials)

lidocaine (xylocaine) (3 trials)

midazolam (versed) (4 trials)

morphine (1 trial)

naproxen (naprosyn) (3 trials)

nitroprusside (nipride) (1 trial)

norepinephrine (levophed) (1 trial)

oxybutynin (ditropan) (1 trial)

propofol (diprivan) (4 trials)

propylthiouracil (1 trial)

rabeprazole (pariet) (1 trial)

remifentanil (ultiva) (5 trials)

rocuronium (zemuron) (2 trials)

sodium chloride (2 trials)

solifenacin (vesicare) (2 trials)

tramadol (Ultram) (2 trials)

Drugs in Phase 3 Trials (22)

albuterol (proventil) (1 trial)

azelastine (astelin) (1 trial)

azithromycin (zithromax) (1 trial)

budesonide (rhinocort) (1 trial)

cefixime (suprax) (1 trial)

clavulanate (Augmentin) (2 trials)

cyclophosphamide (cytoxan) (1 trial)

favipiravir (2 trials)

fentanyl (Innovar) (3 trials)

goserelin (zoladex) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

l-glutamine (1 trial)

melphalan (alkeran) (1 trial)

nitrofurantoin (furadantin) (1 trial)

prednisone (meticorten) (1 trial)

procaine benzylpenicillin (novocaine) (2 trials)

ribavirin (virazole) (1 trial)

ringer's lactate (1 trial)

secukinumab (cosentyx) (1 trial)

terbutaline (bricanyl) (1 trial)

thalidomide (Thalomid) (1 trial)

trimethoprim (1 trial)

Drugs in Phase 2 Trials (7)

autologous hematopoietic stem cells (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

lergopenin (1 trial)

propranolol (inderal) (1 trial)

ritonavir (Norvir) (2 trials)

sch66336 (2 trials)

sufentanil (1 trial)

Drugs in Phase 1 Trials (1)

Balcinrenone (1 trial)

Drugs in Other Trials (27)

beetroot juice (1 trial)

cow milk (1 trial)

dapoxetine (priligy) (1 trial)

darifenacin (enablex) (1 trial)

dextrose (2 trials)

diltiazem (cardizem) (2 trials)

dinoprostone (prostin e2) (1 trial)

epirubicin (ellence) (1 trial)

fesoterodine (toviaz) (1 trial)

furosemide (lasix) (1 trial)

gliclazide (1 trial)

insulin detemir (Levemir) (1 trial)

inulin (1 trial)

isotretinoin (Accutane) (1 trial)

ketamine (ketalar) (1 trial)

lactobacillus casei (1 trial)

lactoferrin (1 trial)

meperidine (demerol) (1 trial)

onabotulinumtoxinA (Botox) (1 trial)

oxytocin (syntocinon) (1 trial)

platelet-rich plasma (1 trial)

propiverine (1 trial)

tadalafil (cialis) (1 trial)

tolterodine (detrol) (1 trial)

vitamin d3 (2 trials)

warfarin (coumadin) (1 trial)

water (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 4)

Anxiety Disorders (Phase 4)

Appendicitis (Phase 3)

Asthma (Phase 3)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Cardiomyopathies (Phase 2)

Cholecystolithiasis (Phase 4)

Cholelithiasis (Phase 4)

Congenital Abnormalities (Phase 3)

Delirium (Phase 4)

Emergence Delirium (Phase 4)

Emergencies (Phase 3)

Enuresis (Phase 4)

Eye Diseases (Phase 4)

Gallstones (Phase 4)

Gastroesophageal Reflux (Phase 4)

Graves Ophthalmopathy (Phase 4)

Heart Failure (Phase 1)

Hepatitis (Phase 2)

Hepatitis D (Phase 2)

Hepatitis D, Chronic (Phase 2)

Hernia (Phase 4)

Hernia, Inguinal (Phase 4)

Hyperplasia (Phase 4)

Infarction (Phase 2)

Kidney Diseases (Phase 3)

Multiple Myeloma (Phase 3)

Myocardial Infarction (Phase 2)

Nausea (Phase 4)

Neoplasms (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Nocturnal Enuresis (Phase 4)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 4)

Peripheral Nervous System Diseases (Phase 3)

Pharyngitis (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Premature Birth (Phase 2)

Prostatic Hyperplasia (Phase 4)

Pruritus (Phase 4)

Psoriasis (Phase 3)

Psychomotor Agitation (Phase 4)

Renal Insufficiency, Chronic (Phase 3)

Retinal Diseases (Phase 2)

Retinopathy of Prematurity (Phase 2)

Thyroid Diseases (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Urinary Incontinence (Phase 4)

Vesico-Ureteral Reflux (Phase 3)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 76
  • # of Trial APIs: 89